[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

AstraZeneca: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market

October 2010 | 97 pages | ID: A21D9EC3F75EN
Venture Planning Group

US$ 1,520.00 US$ 1,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global PDF: US$ 3,900.00

A strategic assessment of AstraZeneca, one of the world’s leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global pharmaceutical market.

Contains 97 pages and 8 tables
I. EXECUTIVE SUMMARY

II. BUSINESS ORGANIZATION

III. SENIOR MANAGEMENT

IV. FACILITIES AND EMPLOYEES

V. TECHNOLOGICAL KNOW-HOW

VI. PRODUCT PORTFOLIO

VII. MARKETING TACTICS

VIII. SALES AND PROFIT GROWTH

IX. R&D EXPENDITURES AND MAJOR PROGRAMS

X. COLLABORATIVE ARRANGEMENTS

XI. STRATEGIC DIRECTION

LIST OF TABLES


Table 1: AstraZeneca Sales and Operating Profit Growth
Table 2: AstraZeneca Sales by Therapeutic Category/Business
Table 3: AstraZeneca Sales Growth by Therapeutic Category/Business
Table 4: AstraZeneca Sales by Major Drug/Business
Table 5: AstraZeneca Sales Growth by Major Drug/Business
Table 6: AstraZeneca Sales by Major Drug/Business and Geographic Region
Table 7: AstraZeneca Sales by Geographic Region and Country
Table 8: AstraZeneca Sales Growth by Geographic Region and Country


More Publications